Russia has registered a rapid HIV test
06 March 2024
The Rapid Bio company (Skolkovo resident) received a registration certificate for a rapid test for early diagnosis of HIV. With its help, you can detect the fact of infection as early as 10-12 days, and the testing time is 8 minutes. The inclusion of the rapid test in the State Register of Medical Devices allows the company to begin its production and sales, the press service of the Skolkovo Foundation told GxP News.
Russia sending rabies and avian influenza vaccines to Brazil
05 March 2024
The Federal Center for Animal Health will send vaccines against rabies and avian influenza to Brazil within the framework of a quadripartite agreement signed on February 20 with the State University of Maringa (UEM), the Federal University of Parana (Universidade Federal do Parana) and the company Belcher Pharmaceuticals (Brazil).
New antibody drug formulation wins novel MHRA approval
05 March 2024
A new formulation of an antibody drug has been authorised via a process from the Medicines and Healthcare products Regulatory Agency (MHRA) that enables “considerably shorter” approval timelines.
A new center for testing drugs on laboratory animals is being considered
04 March 2024
According to Alexey Kochetov, Director of the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, the establishment of national bioresource centers is essential for the generation of genetic lines of laboratory animals to facilitate the advancement of new drugs and preclinical research. Such a step is rational in view of the course towards achieving Russian technological sovereignty in pharmacology and medicine.
A new chapter for biotech: Confidence returns to the market
04 March 2024
After a few years characterised by uncertainty, the narrative across the biotech industry is changing. We have seen a steady upswell in optimism among biotech organisations and other stakeholders over the recent months as new activity announcements set the tone for a ‘return to normal’. The Financial Times noted that the US biotech sector is bouncing back, quoting data from Jeffries that shows January’s capital raised ($6.2bn) reached levels similar to the previous high-water mark of February 2021.
Russia has developed a test that can detect 2,500 hereditary diseases in infants
01 March 2024
A test system has been developed by Russian scientists that can identify approximately 2,500 hereditary diseases in newborns within the first days of their lives. Prime Minister Mikhail Mishustin spoke about this at a strategic session dedicated to socio-economic development.
440 million rubles have been assigned for the bone marrow donation program
01 March 2024
The Russian Prime Minister, Mikhail Mishustin, has approved the allocation of 440 million rubles from the federal budget to bolster the progress of bone marrow and hematopoietic stem cell donation. According to the government website, these funds will be utilized to enhance the accessibility of cutting-edge medical care for patients.
Overcoming challenges of continuous antibody manufacture
29 February 2024
During monoclonal antibody (mAb) manufacture, continuous flowsheets could offer ~20 percent–40 percent cost of goods (COG) saving over the batch process, for instance, during low commercial demand, a paper suggests.
Single-use technology propelling upstream bioprocessing market expansion
29 February 2024
A driving factor behind the expansion of the upstream bioprocessing market is the need for process improvement in the biopharma industry,, research highlights.
Novel immunotherapy approved for melanoma
28 February 2024
The first non-CAR-T adoptive cell therapy to reach the market has been approved by the US Food and Drug Administration (FDA).
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024